Clonal evolution in Philadelphia chromosome negative cells following successful treatment with Imatinib of a CML patient: clinical and biological features of a myelodysplastic syndrome

Leukemia. 2004 Feb;18(2):361-2. doi: 10.1038/sj.leu.2403210.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Benzamides
  • Chromosomes, Human, Pair 8
  • Clone Cells / pathology
  • Female
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / chemically induced*
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / etiology
  • Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative / pathology
  • Middle Aged
  • Myelodysplastic Syndromes / chemically induced
  • Myelodysplastic Syndromes / etiology
  • Myelodysplastic Syndromes / pathology
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Pyrimidines / adverse effects*
  • Pyrimidines / therapeutic use
  • Trisomy

Substances

  • Benzamides
  • Piperazines
  • Pyrimidines
  • Imatinib Mesylate